Free Trial

Atria Investments Inc Trims Holdings in Procter & Gamble Company (The) (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Atria Investments Inc reduced its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 7.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 166,811 shares of the company's stock after selling 14,300 shares during the period. Atria Investments Inc's holdings in Procter & Gamble were worth $28,428,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of PG. Navigoe LLC purchased a new position in Procter & Gamble during the fourth quarter worth about $31,000. Capital A Wealth Management LLC purchased a new position in Procter & Gamble during the fourth quarter worth about $31,000. Hoey Investments Inc. raised its stake in Procter & Gamble by 321.7% during the fourth quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after purchasing an additional 148 shares during the period. 10Elms LLP purchased a new position in Procter & Gamble during the fourth quarter worth about $34,000. Finally, Sunbeam Capital Management LLC purchased a new position in Procter & Gamble during the fourth quarter worth about $34,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Procter & Gamble

In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of the business's stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the sale, the insider owned 25,182 shares in the company, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the sale, the chief executive officer owned 51,965 shares of the company's stock, valued at $8,386,111.70. This represents a 1.89% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Truist Financial reduced their target price on shares of Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Piper Sandler lifted their price target on shares of Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research report on Monday, May 5th. Morgan Stanley set a $180.00 price target on shares of Procter & Gamble and gave the company an "overweight" rating in a research report on Friday, April 25th. Bank of America dropped their price target on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Finally, UBS Group dropped their price target on shares of Procter & Gamble from $186.00 to $180.00 and set a "buy" rating for the company in a research report on Thursday, July 17th. Nine equities research analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $176.12.

Get Our Latest Report on Procter & Gamble

Procter & Gamble Stock Down 0.3%

NYSE PG traded down $0.53 on Friday, hitting $158.28. 5,799,883 shares of the stock were exchanged, compared to its average volume of 9,070,670. The company has a quick ratio of 0.50, a current ratio of 0.71 and a debt-to-equity ratio of 0.47. Procter & Gamble Company has a fifty-two week low of $151.90 and a fifty-two week high of $180.43. The company has a market cap of $371.10 billion, a PE ratio of 25.12, a PEG ratio of 4.52 and a beta of 0.40. The company has a 50-day moving average price of $161.02 and a 200-day moving average price of $164.22.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.53 by $0.01. Procter & Gamble had a net margin of 18.46% and a return on equity of 32.67%. The company had revenue of $19.78 billion during the quarter, compared to analysts' expectations of $20.42 billion. During the same quarter in the previous year, the business posted $1.52 EPS. The firm's revenue was down 2.1% on a year-over-year basis. Sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.67%. Procter & Gamble's dividend payout ratio is presently 67.14%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines